Device Overview
The WATCHMAN FLX Device is indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation.
Intended Use
The device is suitable for patients who are at increased risk for stroke and systemic embolism, are recommended for anticoagulation therapy, and have an appropriate rationale to seek a non-pharmacologic alternative to anticoagulation therapy.
Contraindications and Warnings
The device is contraindicated in patients with intracardiac thrombus, atrial septal defect or patent foramen ovale repair or closure device, and those with known hypersensitivity to device materials.
Implantation should only be performed by trained interventional cardiologists and/or electrophysiologists, and careful consideration should be given to use in pregnant and/or breastfeeding women.
Reimbursement Information
This guide provides an overview of the coding, coverage, and payment landscape for the WATCHMAN FLX LAAC Device, including ICD-10-CM diagnosis codes, hospital reimbursement, physician reimbursement, and professional claim billing instructions.
Manual:
Download: WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE REIMBURSEMENT GUIDE
Chat: Powered By VoiceSphere